EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma

被引:155
作者
Davidson, B [1 ]
Goldberg, I
Berner, A
Kristensen, GB
Reich, R
机构
[1] Univ Oslo, Norwegian Radium Hosp, Dept Pathol, N-0310 Oslo, Norway
[2] Tel Aviv Univ, Sackler Sch Med, Dept Pathol, Sheba Med Ctr, Tel Hashomer, Israel
[3] Univ Oslo, Norwegian Radium Hosp, Dept Gynecol Oncol, N-0310 Oslo, Norway
[4] Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol, Fac Med, IL-91120 Jerusalem, Israel
[5] Hebrew Univ Jerusalem, David R Bloom Ctr Pharm, Jerusalem, Israel
关键词
EMMPRIN; immunohistochemistry; mRNA in situ hybridization; metastasis; ovarian carcinoma; serous effusions; survival;
D O I
10.1023/A:1022696012668
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EMMPRIN is a member of the immunoglobulin superfamily of adhesion molecules and has a role in the activation of several matrix metalloproteinases (MMP). The objective of this study was to investigate the expression of EMMPRIN in effusions, primary and metastatic tumors of serous ovarian carcinoma patients, as well as to evaluate its association with clinicopathologic parameters and with MMP and integrin expression. Eighty effusions and eighty-three solid lesions were evaluated for expression of EMMPRIN mRNA using in situ hybridization (ISH). Protein expression was studied in 75 effusions and 55 biopsies using immunohistochemistry (IHC). EMMPRIN mRNA and protein were detected in carcinoma cells in 63/80 (79%) and 64/75 (85%) effusions, respectively. Expression was similar in peritoneal and pleural effusions. EMMPRIN was co-expressed with MMP-1 (P < 0.001), MMP-9 (P = 0.006) and the αv (P = 0.013) and β1 (P = 0.029) integrin subunits. In solid lesions, EMMPRIN localized most often to tumor cells (51/83 using ISH 51/55 using IHC), but was also expressed in stromal and endothelial cells in approximately one third of the cases. EMMPRIN mRNA expression in tumor cells was most frequent in peritoneal metastases (P = 0.03). EMMPRIN expression in carcinoma cells of solid tumors showed an association with that of MMP-9 (P = 0.018), while labeling of stromal cells showed co-localization with the β1 integrin subunit (P = 0.043). In survival analysis, EMMPRIN protein expression in stromal cells of primary tumors (P = 0.012) and in endothelial cells of all solid tumors (P = 0.023) correlated with poor survival. In conclusion, EMMPRIN is a novel prognostic marker in ovarian carcinoma, and is co-expressed with other metastasis-associated molecules in this malignancy. The identical phenotype of carcinoma cells in pleural and peritoneal effusions provides further evidence to our theory that cells at these sites share similar genotypic and phenotypic profiles.
引用
收藏
页码:161 / 169
页数:9
相关论文
共 36 条
[1]  
Bedrossian CWM, 1994, Malignant Effusions: A Multimodal Approach to Cytologic Diagnosis
[2]   Generation of monoclonal antibodies to integrin-associated proteins - Evidence that alpha(3)beta(1) complexes with EMMPRIN/basigin/OX47/M6 [J].
Berditchevski, F ;
Chang, S ;
Bodorova, J ;
Hemler, ME .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (46) :29174-29180
[3]   Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma - diagnostic and prognostic implications [J].
Berner, HS ;
Davidson, B ;
Berner, A ;
Risberg, B ;
Kristensen, GB ;
Trope, CG ;
Van de Putte, G ;
Nesland, JM .
CLINICAL & EXPERIMENTAL METASTASIS, 2000, 18 (02) :197-202
[4]  
BISWAS C, 1995, CANCER RES, V55, P434
[5]   Expression of the extracellular matrix metalloproteinase inducer (EMMPRIN) and the matrix metalloproteinase-2 in bronchopulmonary and breast lesions [J].
Caudroy, S ;
Polette, M ;
Tournier, JM ;
Burlet, H ;
Toole, B ;
Zucker, S ;
Birembaut, P .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1999, 47 (12) :1575-1580
[6]   Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma:: Evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions [J].
Davidson, B ;
Berner, A ;
Nesland, JM ;
Risberg, B ;
Kristensen, GB ;
Tropé, CG ;
Bryne, M .
HUMAN PATHOLOGY, 2000, 31 (09) :1081-1087
[7]   High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma [J].
Davidson, B ;
Goldberg, I ;
Gotlieb, WH ;
Kopolovic, J ;
Ben-Baruch, G ;
Nesland, JM ;
Berner, A ;
Bryne, M ;
Reich, R .
CLINICAL & EXPERIMENTAL METASTASIS, 1999, 17 (10) :799-808
[8]   Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies -: Evaluation of five epithelial markers [J].
Davidson, B ;
Risberg, B ;
Kristensen, G ;
Kvalheim, G ;
Emilsen, E ;
Bjåmer, A ;
Berner, A .
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1999, 435 (01) :43-49
[9]   Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels [J].
Davidson, B ;
Reich, R ;
Berner, A ;
Givant-Horwitz, V ;
Goldberg, I ;
Risberg, B ;
Kristensen, GB ;
Trope, CG ;
Bryne, M ;
Kopolovic, J ;
Nesland, JM .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (16) :2040-2049
[10]   Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions [J].
Davidson, B ;
Reich, R ;
Kopolovic, J ;
Berner, A ;
Nesland, JM ;
Kristensen, GB ;
Tropé, CG ;
Bryne, M ;
Risberg, B ;
van de Putte, G ;
Goldberg, I .
CLINICAL & EXPERIMENTAL METASTASIS, 2002, 19 (02) :135-144